In a study of 10 children published online in the American Journal of Human Genetics on April 14, the researchers linked a constellation of birth defects affecting the brain, eye, ear, heart and kidney to mutations in a single gene, called RERE.

Renowned UCSF immunologist Jeffrey Bluestone, PhD, has been named president and CEO of the Parker Institute for Cancer Immunotherapy, a national initiative launched with a $250 million grant from The Parker Foundation, established by Silicon Valley entrepreneur Sean Parker.

Oncologist Lawrence Fong is leading UCSF’s newly launched Cancer Immunotherapy Program, a clinic and laboratory dedicated to developing and studying cutting-edge immunotherapy treatments.

Clinicians at UCSF are taking on trauma as more than just a social issue. They are addressing how it has a staggering impact on a person’s health.

UCSF and UC Hastings College of the Law have combined their expertise to offer a new degree program: the Masters of Science program in Health Policy and Law, which begins classes in August.

Bruce Alberts has been named one of the 11 newly elected fellows of the American Association for Cancer Research.

For more than 35 years, dentistry professor Mark Ryder has been devoted to engaging his students during long lectures. His trick: Performing magic routines to illustrate complex scientific concepts.